Robert Azelby
Fortune : 1 M $ au 30/09/2026
Fortune : 1 M $ au 30/09/2026
Mr. Robert W.
Azelby is a Chairman at Tango Therapeutics, Inc., an Independent Director at Cardinal Health, Inc. and an Independent Non-Executive Director at ADC Therapeutics SA. He is on the Board of Directors at Cardinal Health, Inc., Autolus Therapeutics Plc and ADC Therapeutics SA. Mr. Azelby was previously employed as an Independent Director by Terns Pharmaceuticals, Inc., a Chief Executive Officer by Masimo Corp., an Independent Director by Chinook Therapeutics, Inc., a President, Chief Executive Officer & Director by Eliem Therapeutics, Inc., an Independent Director by Clovis Oncology, Inc., a President, Chief Executive Officer & Director by Alder Biopharmaceuticals, Inc., a Chief Commercial Officer & Executive VP by Juno Therapeutics, Inc., a Vice President & General Manager-Oncology by Amgen, Inc., and a VP-Commercial Effectiveness Unit & General Manager by Amgen Europe BV.
He also served on the board at Immunomedics, Inc., CASCADIAN THERAPEUTICS INC and Alliance for Regenerative Medicine.
He received his undergraduate degree from the University of Virginia and an MBA from Harvard Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/09/2026 | 4 085 ( 0 % ) | 908 913 $ | 30/09/2026 | |
TANGO THERAPEUTICS, INC. 0,01 % | 19/06/2026 | 5 740 ( 0,01 % ) | 143 213 $ | 30/09/2026 |
ADC THERAPEUTICS LTD 0,09 % | 03/06/2026 | 112 805 ( 0,09 % ) | 137 622 $ | 30/09/2026 |
| 29/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur/Membre du Conseil | 14/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Directeur/Membre du Conseil | 09/01/2024 |
| CARDINAL HEALTH, INC. | Directeur/Membre du Conseil | 01/03/2024 |
| TANGO THERAPEUTICS, INC. | Président | 06/08/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/05/2026 |
| MASIMO CORPORATION | Directeur Général | 01/02/2025 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 |
| CLOVIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 10/07/2023 |
| CLIMB BIO, INC. | Directeur Général | 13/02/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Cardinal Health, Inc.
Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Immunomedics, Inc.
Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Masimo Corp.
Masimo Corp. Medical SpecialtiesHealth Technology Designs and manufactures non-invasive patient monitoring devices | Health Technology |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Clovis Oncology, Inc.
Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national